Abstract
BACKGROUND
Lack of safe and efficient delivery of siRNA remains the greatest hurdle for the therapeutic application of siRNA. This article
reports synthesis and evaluation of novel lipoidal amine-based nanocarrier (LANC) formulations for siRNA delivery.
METHOD
Physicochemical properties were analyzed for LANC formulations. siRNA delivery efficiency of LANC-siRNA complexes was determined
using a luciferase reporter gene assay. Cytotoxicity of the LANC-siRNA complexes was measured by the MTS assay. Finally, cellular
uptake and cytoplasmic release of siRNA were analyzed using flow cytometry.
CONCLUSION
The LANC formulation facilitated siRNA uptake and release into the cytoplasm, mediating significant luciferase knockdown (70%
inhibition).
Links
Authors
Institution
Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Source
Therapeutic delivery 3:6 2012 Jun pg 715-23MeSH
Biological TransportCell Line, Tumor
Cell Survival
Cytoplasm
Diamines
Flow Cytometry
Gene Therapy
Genes, Reporter
Humans
Lipids
Luciferases
Nanoparticles
Particle Size
RNA Interference
RNA, Small Interfering
Transfection
Pub Type(s)
Journal ArticleResearch Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Language
eng
PubMed ID
22838067
Log In

